ORGO insiders were on both sides of the trade this year. Buys came to roughly $1.1 million (three buyers), sales to $2.7 million (one seller).
The largest purchase came from NUSSDORF GLENN H (Director), about $776,000.
Big money check: 135 institutions held ORGO as of Q2 2026, and more funds bought than sold. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Leibowitz Arthur S | Director | Buy | 5,000 | $2.68 | $13K | SEC |
| Mar 11, 2026 | Driscoll Michael Joseph | Director | Buy | 10,000 | $2.67 | $27K | SEC |
| Dec 18, 2025 | NUSSDORF GLENN H | Director | Sell | 200,000 | $5.14 | $1.0M | SEC |
| Nov 26, 2025 | NUSSDORF GLENN H | Director | Sell | 100,000 | $5.34 | $534K | SEC |
| Nov 26, 2025 | NUSSDORF GLENN H | Director | Sell | 187,957 | $5.29 | $994K | SEC |
| Nov 26, 2025 | NUSSDORF GLENN H | Director | Sell | 12,043 | $5.30 | $64K | SEC |
| Nov 3, 2025 | NUSSDORF GLENN H | Director | Buy | 107,494 | $2.99 | $321K | SEC |
| Nov 3, 2025 | NUSSDORF GLENN H | Director | Sell | 18,620 | $3.56 | $66K | SEC |
| Nov 3, 2025 | NUSSDORF GLENN H | Director | Buy | 251,001 | $3.09 | $776K | SEC |
| Nov 3, 2025 | NUSSDORF GLENN H | Director | Sell | 4,156 | $3.50 | $15K | SEC |
| Jun 6, 2025 | Freedman Lori | Executive Officer | Buy | 100,863 | $2.82 | $284K | SEC |
| Jun 6, 2025 | Freedman Lori | Executive Officer | Buy | 142,379 | $2.91 | $414K | SEC |
| Jun 6, 2025 | Freedman Lori | Executive Officer | Buy | 9,022 | $2.99 | $27K | SEC |
| Mar 6, 2025 | Driscoll Michael Joseph | Director | Sell | 25,000 | $5.10 | $128K | SEC |
| Dec 16, 2024 | Gillheeney Gary S. | CEO | Sell | 5,585 | $3.49 | $19K | SEC |
In the last 12 months Organogenesis Holdings Inc. insiders made open-market purchases worth about $1.1 million and sales worth about $2.7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ORGO was filed on 2026-03-11.
135 investment managers reported holding ORGO in SEC Form 13F filings for Q2 2026.
No congressional trades in ORGO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).